LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83 rd American Academy of ...
A new survey commissioned by Leo Pharma confirms there’s plenty of room in the market for its chronic hand eczema treatment ...
8d
Asian News International on MSNLeo Dryfruits and Spices Trading Launches New Wholly Owned SubsidiaryLeo Dryfruits & Spices Trading Limited, (BSE: 544329), One of the trusted names in the sourcing, processing, trading, and ...
Researchers have found in DELTA China trial that delgocitinib cream (Anzupgo) 20 mg/g significantly reduces severity of ...
Alongside this presentation, new systemic exposure data has also been shared for delgocitinib cream at the meeting. 2 “The data unveiled today further contributes to LEO Pharma’s ever-growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results